Korean J Radiol. 2021 Sep;22(9):1475-1480. English.
Published online Aug 05, 2021.
Copyright © 2021 The Korean Society of Radiology
Review

High-Resolution T2-Weighted MRI to Evaluate Rectal Cancer: Why Variations Matter

Kirsten L Gormly1,2
    • 1Dr Jones and Partners Medical Imaging, Adelaide, Australia.
    • 2The University of Adelaide, Adelaide, Australia.
Received July 08, 2021; Accepted July 12, 2021.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

INTRODUCTION

MRI has been used to image rectal cancer for over two decades and there is extensive research on this imaging technique. The 1999 seminal paper by Brown et al. [1] demonstrated the accuracy of thin-slice MRI in identifying the depth of extramural tumor in 28 patients with rectal cancer. MRI has also been shown to predict involvement of the circumferential resection margin in total mesorectal excision surgery, which is extremely useful to surgeons who may otherwise have produced an R2 resection [2, 3]. MRI has enabled the stratification of patients into high- and low-risk and the selection of appropriate patients for neoadjuvant chemoradiotherapy. It has previously been demonstrated that the thin section, or high-resolution (HR) T2 imaging provided promising results in the assessment of lymph nodes, detection of extramural venous invasion, and differentiation of tumors from fibrosis on post-treatment imaging, which continue to be extensively studied [4, 5, 6].

The majority of publications assessing MRI in rectal cancer describe the use of HR T2 sequences, and the term ‘HR T2’ has been generally accepted to represent HR imaging. There have been a variety of results regarding the accuracy of rectal MRI, particularly the T2 sequence alone, and it has been regularly assessed against other techniques including diffusion, post-contrast, and radiomics. On more in-depth methodological assessment, there is significant heterogeneity in the resolution of the HR T2 sequences across many publications, and this may have an impact on the results.

What Is High-Resolution T2?

The original thin slice HR T2 sequence was defined very clearly by Brown et al. [1], and is used in the MERCURY study protocols and many others [1, 3, 6, 7, 8, 9]. It has an in-plane resolution of 0.6 × 0.6 mm and 3 mm slice thickness, providing a voxel size of 1.08 mm3. The field of view is 160 mm, matrix 256 × 256, with four signal averages. In the year 2000, these scans took over 6 minutes using 1.5T MRI scanners. The resultant scans achieved a high spatial resolution and image quality, which is remarkably similar to that obtained today with the same parameters.

Variations in the parameters producing a larger voxel size, and therefore a lower spatial resolution, have a visible difference on the T2 sequence, as illustrated in Figure 1. These comparative images were obtained on a 1.5T scanner (Aera, Siemens) following intramuscular injection of 20 mg hyoscine butylbromide during the same examination sitting. The sequence parameters are listed in Table 1. A relatively mild increase of the in-plane resolution to 0.8 × 0.8 mm, with a slice thickness of 3 mm, gives a voxel of 1.92 mm3. Hence, this does not meet the MERCURY definition of a HR T2 sequence for rectal MRI. There is a visible reduction in clarity of the rectal wall layers, the internal structure and outline of the lymph nodes and tumor deposits, and a difference in T staging.

Fig. 1
T2 axial oblique images with visible differences in scan quality.
The images have different voxel sizes: 1.08 mm3 (left) and 1.92 mm3 (right). See Table 1 for the sequence parameters.

A. Visible internal heterogeneity of the lymph node (arrows) on higher spatial resolution. B. Increased sharpness of the rectal wall (thin white arrow), internal signal of the lymph node (black arrow), and border of the tumor deposit (thick white arrow). C. Increased visibility of the submucosa in the rectal wall (thin white arrow) and lymph node border irregularity (thick white arrow). D. Differences in the interpretation of an anal sphincter invasion. The scan with voxel 1.08 mm3 shows preservation of the external sphincter low T2 signal (T3) (thick white arrow), but with voxel 1.92 mm3 appears to show tumor signal extending into the external sphincter (T4a) (black arrows). Increased visibility of the intersphincteric plane is evident on the non-involved side (thin white arrow).

Table 1
MRI Parameters for Comparative HR T2 Scans in Figure 1 Using 1.5T Siemens Aera

On reviewing a selection of publications from the past two decades on MRI in rectal cancer, I note that the parameters of the HR T2 sequence have voxels ranging from 0.75 mm3 to 5.4 mm3. In particular, many publications have reported voxels of > 2 mm3, which is greater than the lower-resolution image examples, that demonstrate visible differences. Several papers do not provide sufficient information to calculate the in-plane resolution [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23]. However, all these sequences are usually referred to as HR, and have been accepted in the literature as representing HR T2, with no questions or discussion about the resolution of the sequence and resultant conclusions.

This has implications for the interpretation of individual articles and meta-analyses. In a meta-analysis of MRI assessment of complete response by the Korean Society of Abdominal Radiology, there is a large study heterogeneity for both T2 sensitivity and specificity for diagnosing pathological complete response [24]. The authors commented on the heterogeneity of the criteria adopted by studies to diagnose complete tumor response on T2, but they did not comment on the heterogeneity of the T2 technique assessed. Most of the 17 papers that assessed the T2 technique described the use of a HR T2 technique. However, four did not provide information on the in-plane resolution or voxel size, another four reported voxel sizes of between 1.6 mm3 and 3.5 mm3, and two described ranges that extended significantly above 1.1 mm3. This leaves only seven papers that actually described the HR technique as defined by the MERCURY trials [7, 8, 9, 16, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 28, 29, 30]. When looking at the published images of one study, which concluded that MRI was not useful and did not define their parameters, the field of view appeared quite large, and the image quality was less than expected for HR T2 images. When assessing the forest plot of T2 sensitivity for diagnosing pathological complete response, almost all those to the right of the line met the definition of the HR technique, but only one to the left of the line did. The others reported large voxels or had undefined parameters. Therefore, variation in the technique may impact the results.

International Guidelines and Journals

The variation in the rectal MRI HR T2 technique is contributed to by the lack of standardization among international guidelines. The European Society of Gastrointestinal and Abdominal Radiology (ESGAR) and Society of Abdominal Radiology (SAR) consensus guidelines specify a recommended slice thickness of 3 mm but the in-plane resolution is undefined. The United Kingdom, Canadian, and Australian guidelines specify slice thickness and in-plane resolution. The Korean Society of Abdominal Radiology (KSAR) rectal reporting guidelines do not include a technical section [31, 32, 33, 34, 35, 36]. These variations and the lack of a complete definition in all guidelines means that centers commencing a rectal MRI service may set up lower spatial resolution sequences without realizing that it will affect their ability to achieve a high standard of results. This has an impact on direct clinical care and research excellence.

Editors and reviewers of journals need to be aware of this issue and request the inclusion of the technical parameters so that readers can adequately assess the resolution of the T2 sequences. Many publications do include sequence parameters but do not highlight that the HR T2 definition is not met. The publishers still allow these publications to use the term, HR sequences. Groups performing meta-analyses should also consider the possible effects of lower-resolution parameters on the results. Some articles previously published in the Korean Journal of Radiology did not include the imaging parameters. While these were likely performed with an appropriate HR technique, it is not possible to be certain [12, 15]. I suggest that it is inappropriate to call a sequence HR T2 if it does not meet the specified parameters.

HR T2 in Practice

It is possible to achieve a small voxel and high spatial resolution scan for most magnets. The author commenced a service in Adelaide, Australia in 2004, on an older 1.5T scanner (MAGNETOM Vision, Siemens). While the HR T2 sequences took over 6 minutes to acquire, they were of high diagnostic quality because the MERCURY parameters, including four acquisitions, were applied. We currently perform the majority of our rectal MRI on 1.5T scanners with the sequence parameters listed in Table 2. While the HR T2 sequences are slightly faster on 3T scanners, they still take time. It is important to invest this time as they are the cornerstone of the rectal MRI examination and provide key information about the tumor and mesorectal structures. Using a small voxel HR technique, we can have good visualization of early tumors (Fig. 2), assess the heterogeneity of lymph nodes, and differentiate fibrosis signal from tumor signal on post-treatment scans. With the use of a spasmolytic agent, the HR T2 sequence does not routinely experience significant artifacts and is a reliable, easy-to-use sequence.

Fig. 2
T1 tumour with well-defined wall layers on an high-resolution T2 image.
Muscularis mucosae (thin white arrow), submucosa (black arrow), and muscularis propria (thick white arrow) are shown.

CONCLUSION

HR T2 images are a key part of rectal MRI examination and useful for guiding patient management. It is important to be aware of the true definition of HR T2 and variations in resolution of the HR T2 sequence in the literature. To achieve the best results in day-to-day clinical practice, small voxel, HR parameters should be used. As we seek to improve rectal MRI by testing new sequences and reporting criteria, it is also important to ensure uniformity of the HR T2 sequence, so that the results are meaningful. International guidelines and editors can assist by ensuring that there is a comprehensive definition of the HR T2 sequence within guidelines, and that the parameters are included in all publications.

Notes

Conflicts of Interest:The authors have no potential conflicts of interest to disclose.

References

    1. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215–222.
    1. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001;357:497–504.
    1. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333:779
    1. Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology 2003;227:371–377.
    1. Koh DM, Smith NJ, Swift RI, Brown G. The relationship between MR demonstration of extramural venous invasion and nodal disease in rectal cancer. Clin Med Oncol 2008;2:267–273.
    1. Patel UB, Taylor F, Blomqvist L, George C, Evans H, Tekkis P, et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 2011;29:3753–3760.
    1. Nahas SC, Nahas CSR, Cama GM, de Azambuja RL, Horvat N, Marques CFS, et al. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer. Abdom Radiol (NY) 2019;44:3632–3640.
    1. Jang JK, Lee JL, Park SH, Park HJ, Park IJ, Kim JH, et al. Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer. Br J Surg 2018;105:1671–1679.
    1. Wan L, Zhang C, Zhao Q, Meng Y, Zou S, Yang Y, et al. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Abdom Radiol (NY) 2019;44:2978–2987.
    1. Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004;52:78–83.
    1. Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol 2011;21:1250–1258.
    1. Iannicelli E, Di Renzo S, Ferri M, Pilozzi E, Di Girolamo M, Sapori A, et al. Accuracy of high-resolution MRI with lumen distention in rectal cancer staging and circumferential margin involvement prediction. Korean J Radiol 2014;15:37–44.
    1. Cao W, Lian Y, Liu D, Li F, Zhu P, Zhou Z. Rectal cancer restaging using 3D CUBE vs. 2D T2-weighted technique after neoadjuvant therapy: a diagnostic study. Gastroenterol Rep (Oxf) 2017;5:226–231.
    1. Fornell-Perez R, Perez-Alonso E, Porcel-de-Peralta G, Duran-Castellon A, Vivas-Escalona V, Aranda-Sanchez J, et al. Primary and post-chemoradiotherapy staging using MRI in rectal cancer: the role of diffusion imaging in the assessment of perirectal infiltration. Abdom Radiol (NY) 2019;44:3674–3682.
    1. Yoen H, Park HE, Kim SH, Yoon JH, Hur BY, Bae JS, et al. Prognostic value of tumor regression grade on MR in rectal cancer: a large-scale, single-center experience. Korean J Radiol 2020;21:1065–1076.
    1. Sassen S, de Booij M, Sosef M, Berendsen R, Lammering G, Clarijs R, et al. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol 2013;23:3440–3449.
    1. Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009;253:116–125.
    1. Aker M, Boone D, Chandramohan A, Sizer B, Motson R, Arulampalam T. Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Abdom Radiol (NY) 2018;43:3213–3219.
    1. Zhan S, Wang X, Huang X, Zhu H. Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy. J BUON 2015;20:62–67.
    1. Kuo LJ, Chiou JF, Tai CJ, Chang CC, Kung CH, Lin SE, et al. Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy? Int J Colorectal Dis 2012;27:613–621.
    1. Hanly AM, Ryan EM, Rogers AC, McNamara DA, Madoff RD, Winter DC. Multicenter evaluation of rectal cancer reimaging post neoadjuvant (MERRION) therapy. Ann Surg 2014;259:723–727.
    1. Ko HM, Choi YH, Lee JE, Lee KH, Kim JY, Kim JS. Combination assessment of clinical complete response of patients with rectal cancer following chemoradiotherapy with endoscopy and magnetic resonance imaging. Ann Coloproctol 2019;35:202–208.
    1. Kim S, Han K, Seo N, Kim HJ, Kim MJ, Koom WS, et al. T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 2018;28:5231–5240.
    1. Park SH, Cho SH, Choi SH, Jang JK, Kim MJ, Kim SH, et al. MRI assessment of complete response to preoperative chemoradiation therapy for rectal cancer: 2020 guide for practice from the Korean Society of Abdominal Radiology. Korean J Radiol 2020;21:812–828.
    1. Bhoday J, Smith F, Siddiqui MR, Balyasnikova S, Swift RI, Perez R, et al. Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy. Dis Colon Rectum 2016;59:925–933.
    1. Yoo GS, Park HC, Yu JI, Choi DH, Cho WK, Park YS, et al. Carcinoembryonic antigen improves the performance of magnetic resonance imaging in the prediction of pathologic response after neoadjuvant chemoradiation for patients with rectal cancer. Cancer Res Treat 2020;52:446–454.
    1. Santiago I, Barata M, Figueiredo N, Parés O, Henriques V, Galzerano A, et al. The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer. Eur Radiol 2020;30:224–238.
    1. Sclafani F, Brown G, Cunningham D, Wotherspoon A, Mendes LST, Balyasnikova S, et al. Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer. Br J Cancer 2017;117:1478–1485.
    1. Horvat N, Veeraraghavan H, Khan M, Blazic I, Zheng J, Capanu M, et al. MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy. Radiology 2018;287:833–843.
    1. Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011;18:2224–2231.
    1. Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2018;28:1465–1475.
    1. Gollub MJ, Arya S, Beets-Tan RG, dePrisco G, Gonen M, Jhaveri K, et al. Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY) 2018;43:2893–2902.
    1. The Royal College of Radiologists. Recommendations for cross-sectional imaging in cancer management, second edition. Rcr.ac.uk Web site. [Accessed June 30, 2021].
    1. Kennedy E, Vella ET, Blair Macdonald D, Wong CS, McLeod R. Cancer Care Ontario Preoperative Assessment for Rectal Cancer Guideline Development Group. Optimisation of preoperative assessment in patients diagnosed with rectal cancer. Clin Oncol (R Coll Radiol) 2015;27:225–245.
    1. Cancer Council Australia. Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. Wiki.cancer.org.au Web site. [Accessed June 30, 2021].
    1. KSAR Study Group for Rectal Cancer. Essential items for structured reporting of rectal cancer MRI: 2016 consensus recommendation from the Korean Society of Abdominal Radiology. Korean J Radiol 2017;18:132–151.

Metrics
Share
Figures

1 / 2

Tables

1 / 2

ORCID IDs
PERMALINK